ARQL Archives - Page 2 of 2 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: VTVT Recap & More

vTv Therapeutics, Inc. VTVT

Our report yesterday morning included a look at the VTVT chart, and establishing our interest in tracking it as a bottom play. Our timing in this really could not have been any better as the stock not only made it biggest single session move of the year, but also traded its highest volume.

VTVT ran from a low of .79 and reached as high as 1.67, a 53% intraday rip, and ended up closing at 1.19, filling a portion of the large gap which you can plainly see below. Based on the activity we’ve now witnessed, and the still-ripe look of the chart, we’re going to continue to keep a close watch over VTVT.

Van Eck Vectors Gold Miners ETF (GDX)

We also want to begin tracking a pair of options contracts in the GDX chain. Gold has been doing well and looks as if another solid day could be in the cards.

On that event, there should be some nice activity in the GDX Weekly $22.50 & $23 Calls, so we’ll be monitoring for that.

Tandem Diabetes Care, Inc. TNDM – Update

It was a week ago today that we were commenting on our coverage of TNDM in 2018. We caught this stock at a low of 2.14 earlier this year, and it has come a long way since then.

This week the stock has traded up to a high of 7.75, marking an increase of 262% since we began tracking it.

Extended Watchlist:
TEUM, ARQL, SPWR, PRPO, INPX, USLV, OAS

Blue Horseshoe Stocks: Month-Long Runners

Geron Corp. GERN

It was just on Tuesday morning that we did a review of the performance of GERN, a stock we had initially tagged on February 5th. It had made considerable progress over a six week period, and after a fantastic session yesterday, the stock once again shot to new highs.

It ran all the way to an even 5.00, which from the 2.025 low we observed in early February, marks an increase of 147% This week has brought the highest volume, and now the highest PPS since 2015 for GERN. With the stock well into Blue Skies, we’re be interested to continue following its activity.

DURECT Corp. DRRX

Speaking of stocks on our radar that have enjoyed longer-term success, we want to talk about DRRX again this morning. We’ve been tracking this stock since mid-December (12/14), and in two separate runs here in 2018, we’ve seen it make fantastic progress.

We also included DRRX once again at the beginning of this month, and yet again on Tuesday of this week as the stock has continued to push its way further and further upward. This month alone it has risen from 1.2338 to a new high of 2.20, a gain of 78%

Subsequent to our original alert, DRRX registered a low of .875, and from there, yesterday’s high measures as a 151% increase.

NII Holdings, Inc. NIHD

In yet another month-long gainer, we have NIHD. We signaled out interest in tracking this play back on the last day of February and it has been steadily ramping its way up all month long.

We’ve witnessed a run from a low of 1.115, to yesterday’s new high of 2.28, marking a 104% intra-month move.

Fresh Options Ideas:

Petroleo Brasiliero S.A. PBR 03/23 $14-15 Calls
Conagra Brands, Inc. CAG 04/20 $35 & 36 Calls

Extended Watchlist:
ARQL, ATOS, OMER, RNVA, RSII, RXMD, TRHC, PRPO

Blue Horseshoe Stocks: Recap on RPRX, JNUG, Others

Repros Therapeutics, Inc. RPRX

The primary attraction to come off of our report on Friday was definitely RPRX. The stock had one heck of a solid session, building steadily all day long. It traded from a morning low of 7.66, and reached as high as 10.25 just prior to the close, and did so on volume which exceeded the 3-month average by nearly eight times. That’s a really impressive run from a stock in this price range.

We originally caught RPRX on October 17th after catching the stock gapping down to 52-week lows, and measuring from the low we observed subsequent to that report (5.97), Friday’s high represented an overall increase of 71%

The company is slated to release earnings today >> View Earnings Calendar

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

Also jumping off of Friday’s extended watchlist with a good showing was JNUG. We seemed to have timed our mention of this ETF quite well, with gold prices having bounced off of their annual low on Thursday, it set the stage for JNUG to make a respectable intraday day for us.

It traded in a range from 3.59-4.44, gaining as much as 24% on considerable volume, to the tune of 4.5X it’s 3-month average.

JNUG could be an interesting play moving forward providing the rebound in the price of gold is sustained, so that will be one of the things we’ll be interested to watch for as we kick off a new trading week.

Dendreon Corp. DNDN

DNDN is taking a massive premarket pounding this morning in the wake of the company’s filing for Chapter 11 protection. It’s worth noting, despite the forthcoming restructuring, the company will continue to produce and distribute its PROVENGE immunotherapy treatment, and has declared that it “has significant liquidity to support all of its operations during the restructuring process, with approximately $100 million of cash, cash equivalents and investments on hand as of November 7, 2014” >> View PR

Because of the nature of the situation, we’ll be exercising extreme caution, but we still want to monitor the stock for a bottom and subsequent bounceplay opportunities that could come as a result.

Extended Watchlist:
ACHN, IBIO, ARQL, DVAX, UEC, OIBR

TSLA Options, CANN & Extended Watchlist

Tesla Motors, Inc. TSLA

It isn’t every day that we make options-trading picks, but when we do, they’re usually pretty accurate. On Wednesday, we floated the idea that the TSLA $165 and $170 Weekly Calls were looking attractive, and priming up for possible breakouts. As you can see on the following charts, that assumption proved to be a good one; both contracts would yield opportunities at multi-bag gains.

The $170 Calls were as low as .50 and hit a high of 3.85, representing a 670% move.

The $165 Calls traded from a low of 1.55 up to 7.95 on Thursday, an intraday swing of 413%

In order to squeeze added gains from these contracts, we’ll need to see TSLA stock to hold support at or above 168.80, and we’re looking for a break of resistance at 172.70. Pre-market trades are currently going off in the 171.50-range.

Advanced Cannabis Solutions, Inc. CANN

CANN has been very good to us in the short while we’ve been tracking it (1st alert, 01/08, Low of 6.31). We’ve included it in every newsletter since Tuesday, and every day it has bulled its way to new highs. Yesterday, it hit 23.35, marking a rise of 270% from our initial alert, which came just six trading sessions ago.

This has been one cannabis stock that has sustained its trend quite well, even as movement in some of the others has slowed. However, just because the feeding frenzy we witnessed in the first week of the new year has calmed down, that doesn’t mean we’ve taken our eyes off of the sector. We expect pot stocks to continue to be one of the more popular items on the speculative trader’s agenda in 2014.

Sector Side Note: Easton Pharmaceutical, Inc. EAPH – One of the other marijuana stocks we’ve followed, EAPH had consolidated off of its recent big run and yesterday began to bounce. We might see more significant gain opportunities from EAPH if it can hold support above the .008-level.

Extended Watchlist:
ARIA, NIHD, PBMD, ARQL, KONE, EFUT

FREE, ZLCS, ARQL & Extended Watchlist

FreeSeas, Inc. FREE

It seems yesterday’s news that FREE orchestrated a deal to clean roughly $30M of debt on its balance sheet was well received, as the stock continued its recent unptrend. After we pointed out FREE gapping up into the tune of .63 in yesterday morning’s report, the stock touched a daily low .622 before rocketing to a high of .93, good for a 50% intraday gains.

The 200DMA sitting at .99 is going to be the next major resistance hurdle for FREE. Granted the fact that the stock is up approximately 660% from recent lows, it certainly may be a time to start thinking about taking profits off of the table in anticipation of a pullback.

Zalicus, Inc. ZLCS

ZLCS is a morning gapper that popped up on our scanners today. The stock recently made a nice 94% move (.48-.93) from the beginning of August to the beginning of September. The chart looks ripe, with a recent golden cross taking place, and the stock making higher highs and higher lows. The level of support in September has been .71, and main resistance is sitting at .93. This will be a stock that we want to keep an eye on going forward.

ZLCS is a biopharma company that develops treatments for pain, and currently has a drug undergoing Phase 1b clinical study.

ArQule, Inc. ARQL

Speaking of stair-steppers, ARQL has been on a tear since last Thursday when it touched a low of 2.12. Yesterday the stock reached a high of 2.53, a move of 19%

Both yesterday and the day prior, ARQL had breached the 50DMA at 2.47. We’re watching the stock currently gapping up to the tune of 2.88, up another .41 (+16%) from yesterday’s close. In breaking the 2.80 mark in premarket trading this morning, the stock has surpassed a a recent level of resistance around 2.80. Any time we find a big-board stock with this kind of momentum, we like to pay close attention.

The next levels of resistance that will need to be cleared is sitting at 3.05 and 3.10, swing-highs from May and April, respectively.

Extended Watchlist:

SNTA, AXAS, NEWL, NKE,